Generational Capital Breakout Fund is proud to participate in the Preferential allotment of Beta Drugs (existing long term holding), India’s fastest growing scaled branded formulations player with 5x revenue & profit scale up with 30% ROCE in the last 5 years along with top healthcare Venture Capitalist & FII Healthquad Fund & Inti Capital. The 100 crore raised is expected to further expedite growth as the company has reached critical mass to scale up the oncology vertical. Best regards, Satwik Jain Founder Generational Capital.
Generational Capital Breakout Fund is excited to participate in the preferential issue of E2E Networks , one of fastest growing AI focused hyper scale cloud platforms with 3 yr PAT CAGR of >100% with deep experience of scaling unicorns and SME’s from zero to one like Zomato, India Mart, Purple & first Indian cloud platform to launch H 100’s. The round saw participation from marquee investors like Ashish Kacholia, Alchemy Capital, Niveshaay, Gauri Khan Family Trust among others. The INR 420 crores raised will be used to scale up the fixed asset base.
Generational Capital Breakout Fund is excited to participate in Qualified Institutional Placement of PNGS Gargi- the fastest growing listed fast fashion jewellery chain in the country growing at 100% plus CAGR over the last 3 years. The QIP funds with significant participation from the promoters and marquee investors will be used to make it pan Indian jewellery brand from current focus on the Western region. The business fits within our framework of identifying regional hyperscalers raising growth capital to expand pan India in the consumer sector.
